MedTrace Logo

Intervention Study on Weight Loss in Patients With Obesity

NCT07124832 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-08-29

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting.

The main question it aims to answer is:

-Is Socratic questioning an effective alternative approach for promoting weight loss in patients with obesity?

Researchers will compare participants receiving Socratic questioning during follow-up visits with those receiving regular care to see if the intervention leads to greater weight loss.

Participants will:

* Complete a baseline questionnaire including 9 demographic questions and the 14-item Hospital Anxiety and Depression Scale (approx. 5 minutes).
* Attend five in-person follow-up visits with their family physician over a 3-month period (every 15 or 30 days), where they will receive brief counseling (10-15 minutes per visit) and have their weight, height, and waist circumference measured.
* Complete a 17-question final questionnaire at the end of 3 months (approx. 10-15 minutes).
* Be referred to mental health services if necessary, based on initial screening results.

Conditions

Interventions

BEHAVIORAL

Socratic Questioning Method

Socratic questioning is a method in which behaviour is examined through questions such as "what, where, which, who, when, how, and why". It consists of four stages: defining the problem, evaluating and identifying alternatives, redefining, and discussing feasible outcomes. Through this process, individuals develop their critical thinking skills and make self-evaluations.

Sponsors & Collaborators

  • Sıdıka Ece Yokuş

    lead OTHER

Principal Investigators

  • Raquel Gómez Bravo · Centre Hospitalier Neuro-Psychiatrique, Luxembourg

  • Vinicius Anjos de Almeida · University of São Paulo, Brazil

  • Sandra León Herrera · University of Zaragoza, Spain

  • Sıdıka E. Yokuş · Manisa Celal Bayar University

  • Hüseyin Elbi · Manisa Celal Bayar University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-14
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07124832 on ClinicalTrials.gov